Internal Controls: Regulating The ‘Risks’ and Rewards of A.I. in Healthcare Part 3: Reimagine FDA Regulation for the Digital Age (BY RH, DM, DR)
Dylan Reid(Moskowitz)
![Dylan Reid(Moskowitz)]()
Dylan Reid(Moskowitz)
Government Affairs|Specialized in AI Healthcare|Health Policy and Tech
Come read our latest article Forest Hill Labs: A Health Market Intelligence, Policy, and Thought Leadership Consultancy Internal Controls: Regulating The ‘Risks’ and Rewards of A.I. in Healthcare Part 3: Reimagine FDA Regulation for the Digital Age
Come read our article here.
Sign up at www.foresthilllabs.net or subscribe to Forest Hill Labs: A Health Market Intelligence, Policy, and Thought Leadership Consultancy to get our content!
Digital Health | CEO & Сo-founder at Jelvix | Powering Business Growth through Technology | My content presents the resolution to your business challenges
9 个月Henry Meds' innovative approach to tackling the obesity epidemic and transforming the patient experience is noteworthy. Thanks, Dylan Reid(Moskowitz)
AI Ethics Advisor ? LinkedIn AI top Voice ? Futurist ? Uniting Humanity Ecumenically ? Advocate for Ethics in Tech ? Talks about the Future of Work and AI ?
9 个月That will be no easy job we dont have a single AI directive yet that is trully actionable: we do in medicine like the FDA ! Dylan Reid(Moskowitz)